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ABSTRACT
Introduction: WHO case management algorithm for
paediatric pneumonia relies solely on symptoms of
shortness of breath or cough and tachypnoea for
treatment and has poor diagnostic speciﬁcity, tends to
increase antibiotic resistance. Alternatives, including
oxygen saturation measurement, chest ultrasound and
chest auscultation, exist but with potential
disadvantages. Electronic auscultation has potential for
improved detection of paediatric pneumonia but has yet
to be standardised. The authors aim to investigate the
use of electronic auscultation to improve the speciﬁcity
of the current WHO algorithm in developing countries.
Methods: This study is designed to test the hypothesis
that pulmonary pathology can be differentiated from
normal using computerised lung sound analysis
(CLSA). The authors will record lung sounds from 600
children aged #5 years, 100 each with consolidative
pneumonia, diffuse interstitial pneumonia, asthma,
bronchiolitis, upper respiratory infections and normal
lungs at a children’s hospital in Lima, Peru. The
authors will compare CLSA with the WHO algorithm
and other detection approaches, including physical
exam ﬁndings, chest ultrasound and microbiologic
testing to construct an improved algorithm for
pneumonia diagnosis.
Discussion: This study will develop standardised
methods for electronic auscultation and chest
ultrasound and compare their utility for detection of
pneumonia to standard approaches. Utilising signal
processing techniques, the authors aim to characterise
lung sounds and through machine learning, develop
a classiﬁcation system to distinguish pathologic
sounds. Data will allow a better understanding of the
beneﬁts and limitations of novel diagnostic techniques
in paediatric pneumonia.
INTRODUCTION
Acute lower respiratory infection (ALRI) is
the leading cause of death in children under
5 years of age. Pneumonia alone is respon-
sible for killing 1.6 million children world-
wide. WHO developed a case management
algorithm that relies solely on symptoms of
shortness of breath or cough, an elevated
respiratory rate and chest indrawing for the
diagnosis of pneumonia and administration
of antibiotics and/or referral in resource-
poor areas (table 1). Where successfully
implemented, this algorithm has resulted in
a 30%e40% reduction in case mortality
1 but
has moderate sensitivity and poor speciﬁcity,
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ARTICLE SUMMARY
Article focus
- We seek to characterise lung sounds associated
with different respiratory illnesses in children
using electronic auscultation and determine
whether these sounds can be differentiated
from normal through computerised lung sound
analysis.
- We summarise the study design and methods
with standardised protocols for electronic
auscultation and chest ultrasound in children.
Key message
- We aim to develop a protocol for increased
speciﬁcity of paediatric pneumonia diagnosis in
developing countries.
Strengths and limitations of this study
- Our study is limited by the case deﬁnitions
available. With no gold standard for many
paediatric respiratory diseases, we will rely on
clinical exam ﬁndings and chest radiography.
- By investigating a number of novel and
commonly used diagnostic tools for a variety of
respiratory diseases in children, we will gain
valuable information regarding the diagnostic
potential of each, with a main focus on the
electronic stethoscope.
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Open Access Protocolranging from 16% for children presenting with wheeze
2
and 49% for non-severe pneumonia to 95% for very
severe pneumonia.
3 Hazir and colleagues demonstrated
that over 80% of children with WHO-deﬁned non-severe
pneumonia had normal chest radiographs (CXR)
4 and
that the resulting case management was equivalent to no
treatment in a randomised clinical trial,
5 only further
increasing concern for global antibiotic resistance.
Pneumonia is a pathological process resulting in ﬂuid-
ﬁlled alveoli, and while there are multiple potential
aetiologies, most are infectious. Currently, there is no
gold standard for detection of bacterial pneumonia
requiring treatment. In areas where resources are readily
available, chest radiography and clinical diagnosis serve
as the standard of care for pneumonia detection, but
these are not available in resource-poor settings around
the world. Potential alternatives exist within aspects of the
physical exam and imaging. Supplementing oxygen
saturation measurements with the current WHO algo-
rithm has been shown to increase speciﬁcity
6;h o w e v e r ,
the normal range in healthy children varies with envi-
ronmental factors like altitude.
7 Another promising
alternative for detection of paediatric pneumonia is lung
ultrasound. Ultrasound has the advantage of gathering
information from multiple angles and the ability to detect
air-ﬂuid differences that are present with pneumonia.
Studies suggest that this technique may be more sensitive
than radiography and has the added beneﬁt of lack of
radiation; however, these studies have all lacked power
due to small sample size.
8e13 Cost and availability of
skilled ultrasound technicians may limit use in resource-
poor settings. Chest auscultation is a valuable tool for
detection of respiratory pathology and is used widely in
clinical practice. However, limitations include inter-
listener variability, subjectivity in the interpretation of
lung sounds
14 15 and lack of trained personnel in
resource-poor settings. Electronic auscultation has the
advantage of signal ampliﬁcation and ambient noise
reduction leading to increased signal-to-noise ratio along
with its independence on human ear sensitivity to
different acoustic frequencies. Furthermore, through
computerised lung sound analysis (CLSA), this diagnostic
method results in discrete values from a ﬁnal reading,
thereby facilitating standardisation. With advancement in
electronic stethoscopes and CLSA, there is great potential
for improved diagnosis of paediatric pneumonia where
multiple diagnostic tools are not readily available.
In acoustic signal processing, the two commonly
studied lung sounds are crackles and wheezes, which
constitute unique temporal and frequency characteris-
tics. Crackles have been most commonly associated with
pneumonia, whereas wheezes are often observed in
patients with asthma and bronchiolitis.
16 According to
the Computerised Respiratory Sound Analysis Guide-
lines,
17 the frequency of crackles is characterised in the
spectrum of 200e2000 Hz, while wheezes have
a frequency spectrum of 100e1000 Hz. Wheezes have
continuous waveforms (>100 ms duration) with one or
more tonal components and a dominant frequency
>400 Hz during the expiratory phase. Crackles are short
(<20 ms) non-periodic waveforms with transitory sharp
peaks and broadband frequency content during mid-
inspiratory phase. Timeefrequency decomposition of
lung sounds provides useful information in identifying
and localising adventitious lung sounds in a patient.
Translating the CLSA characterisation of abnormal
lung sounds to clinical practice has yet to be achieved.
There are a few studies demonstrating potential, yet data
are largely lacking, especially in the ﬁeld of paediatrics.
Our group conducted a systematic review and meta-
analysis of studies using CLSA for the detection of
a variety of respiratory disease in adults, which found an
overall sensitivity and speciﬁcity of 80% and 85%,
respectively, when compared with radiologically
conﬁrmed cases, with markedly limited results due to
lack of quality and quantity of available data, as well as
lack of standardisation.
16 18e22
In this study, we seek to use electronic auscultation to
record lung sounds of children with various clinical
diagnoses, pneumonia (diffuse interstitial and lobar),
asthma, bronchiolitis and upper respiratory infection
(URI) in a tertiary care centre in Lima, Peru, and
determine whether they can be differentiated from
normal lung sounds using CLSA. In addition, we aim to
compare with imaging modalities of chest radiography
and ultrasound. We hypothesise that not only will the
sounds proﬁles of each pulmonary disease pathology
differ from normal, but due to unique characteristics of
lung sounds associated with bacterial pneumonia versus
asthma, bronchiolitis or URI, CLSA may allow differen-
tiation of various acute lower respiratory disease
processes. With this information in conjunction with
additional basic clinical information (ie, temperature,
respiratory rate, oxygen saturation), we believe that
a much needed improvement in the detection and case
management of paediatric pneumonia is possible.
Table 1 WHO classiﬁcation of acute lower respiratory
infection in children presenting with cough and/or difﬁcult
breathing
Number of pneumonia
(cough and cold)
Respiratory rate, breaths/minute
<50 (infants 2e11 months)
<40 (children 12e59 months)
No lower chest indrawing
Non-severe pneumonia Respiratory rate, breaths/minute
>50 (infants 2e11 months)
>40 (children 12e59 months)
No lower chest indrawing
Severe pneumonia Lower chest indrawing 6 rapid
breathing
Very severe pneumonia At least one of the following:
Unable to feed
Convulsions
Lethargic
Stridor at rest
Clinically severe malnutrition
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Study objectives
The primary objectives of this study are to characterise
lung sounds associated with various clinical diagnoses,
radiologically conﬁrmed consolidative pneumonia and
diffuse interstitial pneumonia, bronchiolitis, asthma and
URIs, in a paediatric population, and to determine if
these diagnoses can be differentiated from normal
through automated lung sounds analysis and compare
with modalities of imaging, current WHO algorithm for
ALRI case management and microbiological testing. We
then aim to develop a clinical protocol pairing electronic
auscultation with a CLSA algorithm to aid in pneumonia
diagnosis.
Study design
Our design will be a cross-sectional study of lung sounds
and other diagnostic modalities from children 2 to
60 months of age presenting with a primary respiratory
complaint to the Instituto Nacional de Salud del Nin ˜o,
a tertiary care hospital in Lima, Peru. Informed consent
from parents will be obtained in the emergency depart-
ment (ED), asthma ward or pulmonary ward where all
testing will be performed in a single visit. Parents will be
asked to ﬁll out a questionnaire, while the physician
reports relevant aspects of the physical exam. Electronic
auscultation will then be performed, following by
imaging and collection of blood, respiratory, urine and
stool samples.
During the initial phase, we will record lung sounds
from 600 children from 2 to 59 months of age, 100 each
with consolidative pneumonia, diffuse interstitial pneu-
monia, asthma, bronchiolitis, URIs and normal lungs.
The second phase will consist of completing our testing
set for external validity and comparing CLSA with the
current WHO algorithm and other diagnostic tools such
as physical exam ﬁndings, chest ultrasound and micro-
biologic testing in order to construct an improved
algorithm for pneumonia diagnosis.
Study population
Children from 2 to 59 months of age presenting to the
ED or in the asthma or pulmonary ward without a history
of chronic lung disease, excluding asthma, or signiﬁcant
cardiac disease will be invited to participate in the study.
Children with respiratory complaints will be invited to
participate as potential cases, while those without respi-
ratory complaints and no acute respiratory illness within
1 month of presentation will be invited to join the study
as controls.
Children will be considered eligible if their parents or
guardians are able to provide written informed consent,
and they themselves do not require airway management
or non-invasive ventilation. Children will be considered
ineligible if they have chronic lung diseases other than
asthma, such as cystic ﬁbrosis, bronchiectasis and
chronic lung disease of prematurity, or signiﬁcant
congenital heart disease. Patients will be considered
ineligible post-consent if they were found to have more
than one active respiratory diagnosis upon further
testing. Group classiﬁcation also may be modiﬁed post-
consent and further enrolment required depending on
chest x-ray (CXR) ﬁnal readings and microbiological
testing for diagnosis.
Outcomes and case deﬁnitions
Because there is no gold standard for diagnosis, we aim
to compare our results with common case deﬁnitions
and clinical diagnoses by experienced physicians.
Secondary outcomes will incorporate aetiology infor-
mation from standard culture and molecular tech-
niques; however, these additional data will not serve as
the gold standard.
Pneumonia will be initially categorised upon clinical
diagnosis by examining paediatricians at El Instituto
Nacional de Salud del Nin ˜o and further characterised as
consolidative or diffuse interstitial pneumonia given ﬁnal
CXR reading by blinded radiologists from the Johns
Hopkins University. Asthma will be deﬁned by the pres-
ence of wheeze on physical exam, history of asthma and
improvement with bronchodilators. Bronchiolitis will be
deﬁned as the presence of wheeze and difﬁculty
breathing on physical exam and viral symptoms (cough,
rhinorrhoea), no history of asthma and little or no
improvement with bronchodilators if attempted. URI will
be deﬁned as respiration rate <50 breaths per minute
and associated with one or more of the following: clear
nasal secretions, sore or red throat or hoarseness.
Sample size
Our recruitment goal is 600 subjects, 100 each with
consolidative pneumonia, diffuse interstitial pneumonia,
asthma, bronchiolitis, URI and normal lungs. Sample
size was powered to improve speciﬁcity of WHO algo-
rithm upon the addition of electronic auscultation. To
detect an improvement in diagnostic speciﬁcity from
50% (WHO algorithm for paediatric pneumonia) to
80% (CLSA and WHO algorithm) with 95% power and
a of 0.05 between pneumonia and non-pneumonia
cases, we require 70 patients per group in the training
set. We will also recruit a test set consisting of an addi-
tional 30 patients per group (30% of total sample) to
estimate areas under the curve for our diagnostic algo-
rithm. Each group will be over-enrolled by 20 to account
for post-consent ineligibility, for a total of 720.
Study organisation
A.B. PRISMA in Lima, Peru, and Johns Hopkins
University in Baltimore, USA, will provide administrative
oversight for the study. There will be a research coordi-
nator at a central location in Lima, Peru, who will
provide logistical support and management of the study
team. Instituto Nacional de Salud del Nin ˜o will provide
a team of study nurses and physicians to carry out
recruitment, physical examination and collection of
specimens. We have also established prior training by an
experienced ultrasonographer to conduct chest ultraso-
nography. A multidisciplinary team of clinicians, ﬁeld
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from Johns Hopkins University, Tufts University,
Cincinnati Children’s Hospital and Instituto Nacional de
Salud del Nin ˜o will be involved with study design and
conduct, statistical analysis and reporting of results.
Questionnaire
We will ask the parent or guardian about the child’s past
medical history, environmental exposures, access to
healthcare and current respiratory symptoms. We will
enquire about demographic information, nutrition and
vaccination history. We will ask about co-morbidities,
family history and developmental history. Environmental
questions pertained to housing, number of children,
rural versus urban living, parent occupations, smoke and
allergen exposure, and sick contacts. Current respiratory
symptoms were asked of the parent or guardian to
answer subjectively and included rapid breathing, difﬁ-
culty breathing, chest indrawing, cyanosis, cough,
sputum production, audible breath sounds and subjec-
tive fever.
Physical exam and laboratory testing
The initial set of vital signs will be recorded, including
pulse oximetry. During the physical exam, a single
examining physician from the larger group of study
physicians will be responsible for recording ﬁndings for
a given patient with emphasis on the respiratory exam.
Chest retractions, nasal ﬂaring, grunting, stridor and
accessory muscle use will be noted and characterised if
present, along with any adventitious lung sounds
appreciated by physician and study team member on
chest auscultation. Degree of improvement after bron-
chodilators will also be recorded if administered. Addi-
tionally, signs of dehydration and malnutrition will be
reported if present. Laboratory results will be recorded if
evaluated by the ED and include complete blood count,
electrolytes and arterial blood gas.
Electronic auscultation
Parents will be allowed to position the patient supine or
upright. The study team member will listen to eight
auscultation sites using a ThinkLabs ds32a Digital
Stethoscope and mp3 recorder, for 10 s at each site, in
the following order of placement: front top left and
right, fronterolateral bottom right and left, back top
right and left and back bottom left and right (ﬁgure 1).
Auscultation will be performed at the participant’s
normal breathing patterns during recording without
being asked to take deep breaths. We will allow only one
repeat of auscultation if recording is interrupted for any
reason or due to unacceptable signal quality of the ﬁrst
recording.
Lung ultrasound
All participants will receive bilateral lung ultrasonog-
raphy carried out on SonoSite portable ultrasound
machine with HFL38/13e6 MHz and P17/5e1M H z
MicroMaxx
 transducers by a single ultrasound techni-
cian who has been trained to the standardised protocol.
Patients will be examined in the supine position with
each hemithorax divided into six sections: two anterior,
two lateral and two posterior. The posterior area is
deﬁned from the posterior axillary line to the para-
vertebral line. Longitudinal and oblique scans will be
obtained at each of the chest zones. Longitudinal scans
allow visualisation of the ribs with the pleural line under
them.
23 Representative images from each section will be
saved and later transferred to radiologists at an outside
institution.
To assess for pneumonia, two of three radiologists
must agree on the description of ultrasound images
compatible with pneumonia. Consolidation will be
determined by (1) the presence of hypo- or anechoic
images with loss of distinct pleural lines and (2) an
irregular shredded border of the pleural line that is
distinct from the lung line, termed the ‘shred sign’.
Additional signs to be reported will include punctate
hyperechoic images reﬂecting air bronchograms,
decreased lung sliding and homogeneous hypoechoic
images in the pleural space corresponding to pleural
effusions. Interstitial inﬁltrates will be determined by the
presence of ‘lung rockets’, which correlate to three or
more B-lines in a longitudinal view between two ribs.
Additional features to be reported include heteroge-
neous echotexture, air and ﬂuid bronchograms, lung
pulse and additional B-lines.
23
Chest radiography
All case participants will undergo chest radiography. We
will attempt postero-anterior and lateral ﬁlms but will
allow an antero-posterior view if not possible. Digital
images will be sent to a third party reading group
blinded to clinical information. Using WHO stand-
ardisation of CXR interpretation for paediatric pneu-
monia,
24 25 radiologists will comment on quality as
Figure 1 Order of auscultation by electronic stethoscope.
The study team member will listen to each site, starting with ‘A’
for 10 s each.
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ence of pathology as consolidative or interstitial with or
without pleural effusions. Radiographic evidence of
pneumonia will be conﬁrmed by agreement by two of
three radiologist reports for a given patient. Additional
pathologic ﬁndings not previously characterised will also
be recorded and reported to the patient’s physician for
further intervention if necessary.
Microbiological studies
Blood, urine and nasopharyngeal samples will be
collected according to our study design (ﬁgure 2). Blood
samples will be drawn for cultures and sensitivities. Urine
will be tested for detection of pneumococcal antigen and
stored for PCR. Nasopharyngeal swabs will be tested for
respiratory viruses, along with culture and sensitivities.
Respiratory pathogens tested by PCR will include Strepto-
coccus pneumoniae, Haemophilus inﬂuenzae and respiratory
syncytial virus.
Safety
To ensure safety, the researcher collecting data is expe-
rienced with providing care to children. The researcher
will use this experience to minimise any discomfort the
children may have. All blood samples will be collected by
a skilled nurse or phlebotomist.
We will adhere to hospital procedures for avoiding
hospital-acquired infections. We will wash hands with
soap and water or alcohol-based hand sanitizer before
patient contact. We will wear gloves, gowns and mask
when required. We will clean the devices using alcohol
swabs before and after each use.
Data quality and management
Prior to data collection, a Manual of Operations will be
developed to ensure standardisation and reliability and
contain detailed instructions for all study procedures
and guidelines for data collection. The manual will be
revised as needed and distributed to members of the
study team.
All data are recorded ﬁrst on paper case report forms
and subsequently double entered using Microsoft
ACCESS. Data sets will be cross validated and errors
corrected. Electronic lung recordings will be transferred
from the mp3 player to participant-speciﬁc ﬁles on the
study computer at least every other day and backed-up
weekly. Digital CXR images will also be uploaded to these
ﬁles and backed-up similarly.
Analysis of lung sounds and statistics
An important ﬁrst step in CLSA is using common signal
processing techniques to investigate high- and low-
frequency information using methods such as the Short-
time Fourier Transform, wavelet transforms and P-spline
bases. The second step will be extracting signal
processing features to train the classiﬁer.
Based on preliminary recordings to date performed by
our group in Baltimore (ﬁgure 3), we anticipate that
wheeze can be characterised using features from the
Fourier transform, such as the existence and temporal
stability of tonal peaks in the 300e1000 Hz range, while
crackles could be recognised using features such as
amplitude, the presence of broadband energy and the
duration of this energy. Features such as the decrease in
signal energy with frequency can characterise movement
sounds. We have previously used timeefrequency
descriptors such as Mel-frequency cepstral coefﬁcients as
features and anticipate they will be useful for CLSA but
may require temporal information as well. We will use
the extracted features from signal processing analyses for
classiﬁcation using machine learning algorithms
including: nearest neighbour methods, support vector
machines, random forests and gradient boosting.
Primary analysis will consist of a ﬁvefold cross validation
on the training set to calculate expected prediction
errors. The training set will additionally be used to esti-
mate areas under the curve for our diagnostic algorithm,
including CLSA, WHO algorithm, imaging and physical
exam ﬁndings. Secondary analysis will include calcu-
lating sensitivities and speciﬁcities of experimental
diagnostic ultrasound for detection of pneumonia when
compared with gold standards (clinical diagnosis and
CXR reading). Performance will be measured using
logistic and multinomial regression, receiver operating
characteristic curves and area under the curve.
DISCUSSION
This study aims to investigate alternatives to improve the
speciﬁcity of WHO algorithm for paediatric pneumonia,
namely electronic auscultation and chest ultrasonog-
raphy. Utilising electronic auscultation, we intend to
characterise and analyse lung sounds associated with Figure 2 Microbiology testing schematic.
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bronchiolitis, asthma and URIs to determine if these
diagnoses can be differentiated from normal through
automated lung sounds and to compare with chest
ultrasound, WHO algorithm and molecular testing for
aetiology. By reporting a protocol for CLSA, we hope to
encourage standardisation and expansion of recorded
lung sounds via an online library for continued
enhancement of machine learning as well as for
continued scientiﬁc research and clinical education.
We foresee our greatest challenge in maximising the
quality of recorded lung sounds. To begin the study, we
will use a commercial electronic stethoscope for record-
ings, which is identical in design to standard clinical
stethoscopes. However, through sound processing using
timeefrequency analysis methods such as the Short-time
Fourier Transform and Continuous Wavelet Transforms,
we hope to enhance the signal-to-noise ratio for data
analysis and characterisation. By examining additional
features such as amplitude, we may also be better able to
identify crackles and consolidation. We also plan to test
alternative recording devices using piezoelectric micro-
phones covered with a thin polymer that may be able to
better capture lung sounds. Based on our recordings to
date, we anticipate that wheeze can be differentiated
from normal breath using features such as the existence
and temporal stability of tonal peaks in the 300e1000 Hz
range, while crackle should be recognisable using
features such as the presence of broadband energy and
the duration of this energy. Features such as the decrease
in signal energy with frequency can characterise move-
ment sounds. We have previously used timeefrequency
descriptors borrowed from speech processing (Mel-
frequency cepstral coefﬁcients and their time derivatives)
and cough-speciﬁc time-domain features such as signal
rise time and event duration and anticipate they will be
useful for CLSA. We will use the extracted features from
signal processing analyses for classiﬁcation using
machine learning algorithms such as nearest neighbour
methods, support vector machines or random forests.
The largest challenge in regards to lung ultrasound
will likely be obtaining adequate quality of images and
inter-user variability. To reduce variability, the study
technician will be trained to systematically scan each
subdivided hemithorax for pathologic ﬁndings
described previously,
9 23 and if possible, we will attempt
lung ultrasound twice for each patient. Ultrasound also
takes substantially longer compared with chest radiog-
raphy because all areas must be adequately explored;
therefore, it may be difﬁcult for a child to be cooperative
for that length of time. Through our large sample size
and detailed methods, we aim to improve stand-
ardisation of paediatric chest ultrasound and further
deﬁne pathologic ﬁndings associated with disease, which
may also lead to more efﬁcient and faster scanning.
Limitations to this study centre mostly on our case
deﬁnitions for clinical diagnoses. As mentioned previ-
ously, there are no precise gold standards and as with
many paediatric diseases, diagnosis is clinical. As such,
our end points are determined by clinical exam ﬁndings
by single examining physicians with additional conﬁr-
mation via radiology for pneumonia cases only. We
acknowledge the variability of observed ﬁndings among
physicians and accept that this is the mechanism of
diagnosis in most clinical settings.
WHO algorithm for case management of paediatric
pneumonia lacks diagnostic speciﬁcity. While clinical
information such as elevated heart rate and decreased
oxygen saturation may aid in degree of illness and
monitoring, these data also lack speciﬁcity required to
drastically improve case management. Lung ultrasound
is also a promising tool and offers portability that is not
available for radiography. Ultrasound has the added
beneﬁt of pleural effusion detection, which may prove
an important adjunct to the electronic auscultation
algorithm. However, cost and availability of skilled tech-
nicians may greatly hamper its utility in resource-poor
settings, similar to microbiologic testing. Electronic
auscultation is a simple inexpensive tool that could have
great diagnostic impact on ALRI in children worldwide.
Through further research, we foresee utilising this tool
with pre-programmed computerised analysis to improve
case management in developing countries.
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